Editor
While Illumina has yet to receive any reports indicating this vulnerability has been exploited, according to a letter to healthcare providers from the U.S. Food and Drug Administration, bad actors could take control of the devices, alter the software and patient test results or compromise a provider’s network and exfiltrate protected data.
WHY IT MATTERS
The FDA released a statement Thursday for healthcare providers and laboratory personnel…
